Francisca Alcayaga

Title: Innovations in Anti-Angiogenic Therapy by Francisca Alcayaga

Introduction

Francisca Alcayaga is an innovative inventor based in Santiago, Chile. She has made significant contributions to the field of medical research, particularly in the area of cancer treatment. Her work focuses on developing alternative therapies that address critical health challenges.

Latest Patents

Alcayaga holds a patent for an invention titled "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells." This groundbreaking invention provides a solution to the lack of effective alternative methods for treating angiogenesis. It is the first to demonstrate that a substantially pure population of exosomes derived from menstrual stem cells (MenSCs) can reduce tumor angiogenesis in various cancers, including prostate, breast, and pancreatic cancer. The invention shows that these exosomes can lower the levels of reactive oxygen species (ROS) in cancer cells and decrease the expression of pro-angiogenic factors such as VEGF, NF-KB, FGF, and HIF-α in treated tumors. Overall, this invention offers a promising alternative method for treating angiogenesis, utilizing exosomes produced by stem cells found in menstrual fluid, which allows for easy access and non-invasive sampling.

Career Highlights

Francisca Alcayaga is associated with Cells for Cells S.A., where she continues to advance her research and innovations. Her work is pivotal in the development of new therapeutic strategies that could significantly impact cancer treatment.

Collaborations

Alcayaga collaborates with Maroun Khoury, who is also involved in the research and development of innovative medical solutions.

Conclusion

Francisca Alcayaga's contributions to anti-angiogenic therapy represent a significant advancement in cancer treatment. Her innovative approach using exosomes derived from menstrual stem cells offers new hope for patients facing challenging health conditions.